Skip to content

Clinical trials

Phase 3 Lymphoma, Non-Hodgkin trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 3 Country / region: Australia Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20071
20091
20101
20113
20121
20131
20141
20151
20162
20173
20193
20201
20215
20223
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting13
Terminated4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
Genmab3
Hoffmann-La Roche3
Pharmacyclics LLC.3
Acerta Pharma BV2
Bayer2
AbbVie1
Amgen1
Baxalta now part of Shire1
BeOne Medicines1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin34
Lymphoma10
Lymphoma, B-Cell9
Leukemia, Lymphocytic, Chronic, B-Cell8
Lymphoma, Mantle-Cell8
Hematologic Diseases6
Lymphoma, Follicular6
Lymphoma, Large B-Cell, Diffuse6
Neoplasms5
Hodgkin Disease3

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.